Navamedic is a Nordic pharmaceutical company dedicated to enhancing people’s quality of life by being a reliable supplier of high-quality prescription, hospital, and consumer health products.
The Navamedic growing product portfolio has been carefully selected to meet current public health concerns, such as obesity, Parkinson’s Disease, addiction and antibiotics, empowering people to live healthier and more fulfilling lives.
What sets us apart is our local insight and competence that enables us to understand the needs and requirements of the patients and payors in the countries where we are present.
This makes us a preferred partner for international companies expanding their footprint across the Nordics and Benelux regions. At the same time, we are building our own portfolio of unique products with international market potential.
We are we looking for?
We have strong growth ambitions and are constantly looking for new partnering opportunities – new products to acquire or launch in our territory and partners to market our own products internationally.
Navamedic has been listed on the Oslo Stock Exchange since 2006 (ticker: NAVA) and is headquartered in Oslo, Norway.
How to contact us?
We will be very pleased to meeting you at the Europharm International Business Meeting in Berlin on the 16h & 17th April 2026 www.europharmbusinessmeeting.com
Ole Henrik Eriksen
Chief Business Development Officer
Mob: +47 400 62000
Email: ole.henrik.eriksen@navamedic.com
Navamedic ASA
Henrik Ibsens gt 100
0255 Oslo
NORWAY
www.navamedic.com